Molecular genotyping of Babesia caballi

Alicia Venter1, Ilse Vorster1, Nokuzola Faith Nkosi1

  • 1Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Private Bag X04, Onderstepoort 0110, South Africa.

PubMed

Insights

New molecular typing assays can now rapidly detect and quantify distinct Babesia caballi genotypes (B and C) in horses. This advancement aids in preventing the spread of equine piroplasmosis variants globally.

Area of Science:

  • Veterinary Parasitology
  • Molecular Diagnostics
  • Equine Health

Background:

  • Babesia caballi causes equine piroplasmosis, with three genotypes (A, B, C) identified.
  • Existing serological assays struggle to detect diverse B. caballi genotypes, impacting disease-free declarations.
  • The diagnostic potential of the spherical body protein 4 (sbp4) antigen across geographical strains is unknown.

Purpose of the Study:

  • To develop and validate molecular typing assays for rapid detection and quantification of distinct B. caballi genotypes.
  • To assess the utility of the sbp4 gene for differentiating B. caballi genotypes.
  • To improve diagnostic capabilities for controlling the spread of equine piroplasmosis.

Main Methods:

  • Phylogenetic analysis of 18S rRNA and sbp4 genes from South African isolates.
  • Design of genotype-specific TaqMan minor-groove binder (MGB™) probes and primer pairs based on sbp4 gene sequence alignment.
  • Screening of field samples using a multiplex equine piroplasmosis qPCR assay.

Main Results:

  • South African B. caballi isolates were phylogenetically grouped into genotypes B or C; genotype A was not detected in field samples.
  • Developed qPCR assays demonstrated specificity and efficiency in differentiating B. caballi genotypes A, B, and C.
  • The sbp4 gene proved valuable for molecular typing and differentiating B. caballi genotypes.

Conclusions:

  • The novel qPCR assays enable accurate differentiation of B. caballi genotypes A, B, and C.
  • These assays can serve as a crucial diagnostic tool to prevent the global dissemination of B. caballi variants.
  • Improved molecular diagnostics are essential for managing equine piroplasmosis effectively.